BBIO.BBio-Rad Laboratories, Inc. Class B

Market capitalisation

9.8bn

Price / earnings

13.0

Price / sales

3.8

Price / book

1.4

Return on equity

11.09 %

Return on assets

7.76 %

Net margin

29.42 %

Operating margin

1.83 %

Current ratio

3.2

Revenue, last year

2.6bn

Net income, last year

760m

Earnings per share

27.85

Revenue growth, year over year

+0.65 %

No events for this security recently.

There is no company information yet.